SEK 4.2 million grant to explore the impact of daily exposure to hormone-disrupting chemicals on fertility outcomes

by Mette Bach Dyremose | Dec 2, 2024 | News

Congratulations to Lars Rylander at Lund University and Sandra Søgaard Tøttenborg, Bispebjerg Hospital, as well as a wider ReproUnion research team for securing a SEK 4.2 million grant from the Swedish Research Council in October 2024. The aim of the funded project is...

MVA Summit features RUBIC: The golden egg in women’s and men’s fertility research

by Mette Bach Dyremose | Nov 28, 2024 | News

With the OL-related theme ‘Faster, higher and stronger – together’ this year’s Medicon Valley Alliance Summit gathered over 200 people from the Danish, Swedish and international life science community. In one of the four sessions, ReproUnion...

ReproUnion gains media attention in both Finland and Sweden

by Mette Bach Dyremose | Nov 18, 2024 | News

In November Altinget.se featured an opinion piece in connection with Father’s Day in Sweden, which called for new ways of supporting infertile couples. And in October the Finnish newspaper Helsingin Sanomat highlighted the collaborative ecosystem of Medicon Valley,...

ReproUnion receives EUR 6.7 million to establish an innovation platform in the fight against infertility

by Mette Bach Dyremose | Jun 22, 2023 | News

In June 2023 ReproUnion was awarded 6.7 million euros to promote innovation in research and treatment of infertility, by establishing an innovation platform with new opportunities to reduce the risk of involuntary childlessness and improve fertility treatment. “The...

New funding to assess if fertility counselling has an impact on family building

by Mette Bach Dyremose | Oct 14, 2022 | News

The first fertility counselling clinic (FAC) opened at Rigshospitalet in 2011 with support from ReproUnion. Since then, more than 3,700 women and men have consulted FAC to examine their fertility potential and get more general advice on age, lifestyle, and the chance...